China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 23.28 CNY -0.47% Market Closed
Market Cap: 11.7B CNY

Intrinsic Value

The intrinsic value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 23.28 CNY, China Resources Boya Bio pharmaceutical Group Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

China Resources Boya Bio pharmaceutical Group Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
China Resources Boya Bio pharmaceutical Group Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

China Resources Boya Bio pharmaceutical Group Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if China Resources Boya Bio pharmaceutical Group Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about China Resources Boya Bio pharmaceutical Group Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is China Resources Boya Bio pharmaceutical Group Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for China Resources Boya Bio pharmaceutical Group Co Ltd.

Explain Valuation
Compare China Resources Boya Bio pharmaceutical Group Co Ltd to

Fundamental Analysis

China Resources Boya Bio pharmaceutical Group Co Ltd
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about China Resources Boya Bio pharmaceutical Group Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
China Resources Boya Bio pharmaceutical Group Co Ltd

Current Assets 5B
Cash & Short-Term Investments 3.2B
Receivables 787.5m
Other Current Assets 1B
Non-Current Assets 3.7B
Long-Term Investments 419.5m
PP&E 1.6B
Intangibles 1.6B
Other Non-Current Assets 107.1m
Current Liabilities 897.9m
Accounts Payable 506.2m
Accrued Liabilities 101.8m
Other Current Liabilities 289.9m
Non-Current Liabilities 151.5m
Long-Term Debt 4.9m
Other Non-Current Liabilities 146.6m
Efficiency

Free Cash Flow Analysis
China Resources Boya Bio pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
China Resources Boya Bio pharmaceutical Group Co Ltd

Revenue
2B CNY
Cost of Revenue
-893.2m CNY
Gross Profit
1.1B CNY
Operating Expenses
-833.7m CNY
Operating Income
236.8m CNY
Other Expenses
90.4m CNY
Net Income
327.2m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

China Resources Boya Bio pharmaceutical Group Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Healthy Net Margin
Sustainable 3Y Average Operating Margin
hidden
Profitability
Score

China Resources Boya Bio pharmaceutical Group Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

China Resources Boya Bio pharmaceutical Group Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

China Resources Boya Bio pharmaceutical Group Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
China Resources Boya Bio pharmaceutical Group Co Ltd

Wall Street analysts forecast China Resources Boya Bio pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 31.78 CNY with a low forecast of 28.28 CNY and a high forecast of 36.75 CNY.

Lowest
Price Target
28.28 CNY
21% Upside
Average
Price Target
31.78 CNY
36% Upside
Highest
Price Target
36.75 CNY
58% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for China Resources Boya Bio pharmaceutical Group Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock?

The intrinsic value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock under the Base Case scenario is hidden CNY.

Is China Resources Boya Bio pharmaceutical Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 23.28 CNY, China Resources Boya Bio pharmaceutical Group Co Ltd is hidden .

Back to Top